Sustainability Summary
- This is an unclaimed profile. IN VIVO has not joined Sustainability Tracker to verify their sustainability credentials. We gathered what we could from public sources.
IN VIVO’s sustainability-related coverage focuses on ESG topics in the life sciences, medtech and pharmaceutical sectors, including diversity and inclusion, women’s health, clinical trial representation, decarbonisation, and environmental sustainability in research and manufacturing. The content highlights industry efforts to reduce emissions, improve sustainability across Scope 1, 2 and 3, and address the environmental impact of medicines production. It also covers broader social issues within ESG, such as leadership representation and sex-specific analysis in clinical research. The page is primarily editorial, presenting sustainability as a material issue for healthcare and life sciences companies.
IN VIVO Sustainability Actions
IN VIVO Sustainability Commitments
2050
Net-zero emissions target
We have set ambitious climate targets as a company. Meron M., our Vice President of Corporate Social Responsibility & Sustainability, recently spoke with In Vivo for their “E” in ESG series about how we engage all stakeholders in our journey toward net-zero emissions by 2050.
